EUVIMEDEUVIMED entdecken
ÄquivalenzstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Simulated daylight vs. conventional PDT for clinical superficial BCC : A randomized controlled trial

Alexandra Sjöholm iD, Eva Backman iD, Maja Modin, Julia Fougelberg iD, Magdalena Claeson iD, John Paoli iD

Journal of the European Academy of Dermatology and Venereology · 2025

DOI: 10.1111/jdv.20602 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2025. Verfasst von Alexandra Sjöholm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Photochemotherapy, Skin Neoplasms, Sunlight. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish State Under the Agreement Between the Swedish Government and the County Councils, the ALF-Agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Photodynamic therapy (PDT) is a recognized treatment for superficial basal cell carcinoma (sBCC). Conventional PDT (C‐PDT) has a relatively high clearance rate but is time‐consuming and painful. Simulated daylight PDT (SDL‐PDT) has the potential advantage of causing less pain, but its effectiveness has not been investigated thoroughly.

Objectives

To determine whether SDL‐PDT is non‐inferior to C‐PDT in the treatment of clinically diagnosed sBCC and to assess adverse events during treatment and patient preferences.

Methods

In this single‐centre, non‐inferiority, randomized controlled trial, adult patients with sBCCs of any size and located on anatomical sites suitable for PDT were recruited. Lesions were randomized to two sessions of either SDL‐PDT or C‐PDT using aminolevulinic acid as the photosensitizer. Patient‐perceived pain was measured using a numeric rating scale (NRS) ranging from 0 to 10. Self‐report forms were used to measure patient preferences. Patients were evaluated after 3 months to assess early treatment failure and after 1 year to determine overall clearance rates.

Results

In total, 78 participants with 193 sBCCs were treated. Most lesions (47.2%) were located on the trunk and were diagnosed solely through dermoscopic evaluation (64.2%). After 1 year, the clearance rate was 62.4% for SDL‐PDT and 91.8% for C‐PDT ( p < 0.001) disproving non‐inferiority. Illumination was reported to be more painful during C‐PDT (mean NRS score of 3.5 at session 1 and 3.7 at session 2) compared with SDL‐PDT (mean NRS score of 0.1 at both sessions) ( p < 0.001). Immediately after treatment, 87.5% of respondents expressed a preference for SDL‐PDT.

Conclusions

SDL‐PDT is less effective than C‐PDT but is also less painful. Due to the lower clearance rate, this study does not support SDL‐PDT as a primary treatment option for sBCC. The randomized controlled trial was registered at http://www.researchweb.org/ (project 264721).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaPhotochemotherapySkin NeoplasmsSunlightAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAminolevulinic AcidPatient PreferencePhotosensitizing Agents

Substanzen

Aminolevulinic AcidPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Dermatology and Venereology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.

ORCID-Profile: Alexandra Sjöholm, Eva Backman, Julia Fougelberg, Magdalena Claeson, John Paoli

Förderung

  • Swedish State Under the Agreement Between the Swedish Government and the County Councils, the ALF-Agreement

Zitieren

APA

Sjöholm, A., Backman, E., Modin, M., Fougelberg, J., Claeson, M., & Paoli, J. (2025). Simulated daylight vs. conventional PDT for clinical superficial BCC : A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20602

Vancouver

Sjöholm A, Backman E, Modin M, Fougelberg J, Claeson M, Paoli J. Simulated daylight vs. conventional PDT for clinical superficial BCC : A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology. 2025. doi:10.1111/jdv.20602

BibTeX
@article{Sjholm2025,
  author = {Sjöholm, Alexandra and Backman, Eva and Modin, Maja and Fougelberg, Julia and Claeson, Magdalena and Paoli, John},
  title = {Simulated daylight vs. conventional PDT for clinical superficial BCC : A randomized controlled trial},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  doi = {10.1111/jdv.20602}
}
Kostenlos starten →